What are the Challenges in Targeting the FA Pathway?
Targeting the FA pathway presents several challenges. One major issue is the potential for increased toxicity in normal cells, as these pathways are also crucial for normal cellular functions. Moreover, the genetic heterogeneity of cancers associated with FA pathway defects can complicate treatment strategies. Precision medicine approaches, which tailor therapy based on individual genetic profiles, may help overcome some of these challenges.
